11-47333640-C-T
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 0P and 3B. BP4_ModerateBP6
The NM_000256.3(MYBPC3):c.3107G>A(p.Arg1036His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000709 in 1,608,378 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1036C) has been classified as Benign.
Frequency
Consequence
NM_000256.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYBPC3 | ENST00000545968.6 | c.3107G>A | p.Arg1036His | missense_variant | Exon 29 of 35 | 5 | NM_000256.3 | ENSP00000442795.1 | ||
MYBPC3 | ENST00000399249.6 | c.3107G>A | p.Arg1036His | missense_variant | Exon 28 of 34 | 5 | ENSP00000382193.2 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152240Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000612 AC: 15AN: 245264Hom.: 0 AF XY: 0.0000674 AC XY: 9AN XY: 133494
GnomAD4 exome AF: 0.0000714 AC: 104AN: 1456138Hom.: 0 Cov.: 32 AF XY: 0.0000649 AC XY: 47AN XY: 724692
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152240Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74368
ClinVar
Submissions by phenotype
Cardiomyopathy Uncertain:2
- -
This missense variant replaces arginine with histidine at codon 1036 of the MYBPC3 protein. Computational prediction tools indicate that this variant has a neutral impact on protein structure and function. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in individuals affected with hypertrophic cardiomyopathy (PMID: 25351510, 26914223, 28356264). This variant has been identified in 17/276658 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
not specified Uncertain:1Benign:1
p.Arg1036His in exon 29 of MYBPC3: This variant is not expected to have clinical significance due to a lack of conservation across species, including mammals. O f note, 10 mammals have a histidine (His) at this position despite high nearby a mino acid conservation. This variant has also been identified in 1 individual wi th HCM (Lopes 2015) and 6/66506 of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs374255381). -
The R1036H variant has been reported in one patient with HCM (Lopes et al., 2015); however, familial segregation information, in vitro functional studies and additional clinical information was not included. The R1036H variant was not observed with any significant frequency in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project. However, the R1036H variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. Additionally, this substitution occurs at a position that is not conserved across species and where H1036 is the wild type in several species. Finally, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is pathogenic or rare benign. -
not provided Benign:2
- -
- -
Hypertrophic cardiomyopathy Uncertain:1
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 1036 of the MYBPC3 protein (p.Arg1036His). This variant is present in population databases (rs374255381, gnomAD 0.01%). This missense change has been observed in individual(s) with hypertrophic cardiomyopathy (PMID: 25351510, 28356264). ClinVar contains an entry for this variant (Variation ID: 181000). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The histidine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Uncertain:1
The p.R1036H variant (also known as c.3107G>A), located in coding exon 29 of the MYBPC3 gene, results from a G to A substitution at nucleotide position 3107. The arginine at codon 1036 is replaced by histidine, an amino acid with highly similar properties. This alteration has been reported in hypertrophic cardiomyopathy (HCM) cohorts; however, clinical details were limited and other cardiac-related alterations were identified in some individuals (Lopes LR et al. Heart, 2015 Feb;101:294-301; Murphy SL et al. J Cardiovasc Transl Res. 2016 Apr;9(2):153-61 Gómez J et al. Circ Cardiovasc Genet, 2017 Apr;10). This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at